Back
Speaker illustration

Doctor Guiomar Mendieta Badimon

Hospital de la Santa Creu i Sant Pau, Barcelona (Spain)

Member of:

European Society of Cardiology

Guiomar Mendieta MD PhD MSc FESC is currently a Clinical Cardiologist at the Department of Cardiology, Hospital de la Santa Creu i Sant Pau, Barcelona. She obtained her MD from the Autonomous University of Barcelona, Spain (2014), and completed her residency in Cardiology at Hospital Clínic Barcelona (2015–2020). She conducted translational research in cardioprotection in ischaemic heart disease, earning her PhD in Medicine from the University of Barcelona in 2020. Previous appointments include physician-scientist at CNIC in Madrid (2020-2022), Clinical Cardiologist and Cardiac Imaging fellow at Hospital Clinic and Clinical Scientist at IDIBAPS Barcelona (2023-2024). She holds an MSc in Epidemiology (LSHTM, London, 2021) and a Postgraduate Course in Heart Failure certificate (European Heart Academy, ESC-HF), Zurich, 2022. She has published over 60 peer-reviewed articles and 6 book chapters.

Presentations Articles

Inflammation and LDL cholesterol contribute independently to the progression of early human atherosclerotic plaque

Event: ESC Congress 2025

Topic: Imaging

Session: Risk factors (4)

Access
Like
Thumbnail

Effect of aspirin discontinuation according to individualised patient bleeding and ischemic risks after PCI: a TWILIGHT trial sub-analysis.

Event: ESC Congress 2022

Topic: Complications

Session: Optimising PCI: imaging, pharmacology and more

Access
Like
Thumbnail

CMR analysis of the cardioprotective effects of chronic statin therapy prior to first STEMI: a propensity score analysis

Event: ESC Congress 2021 - The Digital Experience

Topic: ST-Elevation Myocardial Infarction (STEMI)

Session: Acute Coronary Syndromes ePosters

Access
Like
Thumbnail

Interatrial block: a prognostic factor for atrial fibrillation in cryptogenic stroke patients

Event: ESC Congress 2019

Topic: Stroke in Atrial Fibrillation

Session: Epidemiology of atrial fibrillation

Access
Like
Thumbnail

Intravenous administration of IV-STATIN CARDIOSHIELD during myocardial infarction renders higher cardioprotection than oral atorvastatin given shortly after reperfusion: a translational CMR study

Event: ESC Congress 2019

Topic: Pharmacotherapy

Session: Young Investigator Award Session Thrombosis

Access
Like
Thumbnail

Treating ischemic injury to reduce infarct size and achieve cardiac protection

Event: Acute Cardiovascular Care 2019

Topic: Acute Myocardial Ischaemia

Session: Moderated Poster 6: Acute Coronary Syndromes I

Access
Like
Thumbnail

Interatrial block and reduced global left atrial strain are related to atrial fibrillation onset in patients with cryptogenic stroke

Event: EuroEcho-Imaging 2018

Topic: Tissue Doppler, Speckle Tracking and Strain Imaging

Session: Tissue Doppler, Speckle Tracking and Strain Imaging

Access
Like
Thumbnail

Ticagrelor improves cardiac function and post-myocardial infarction healing: cardiac magnetic resonance imaging assessment of functional, anatomical and remodeling parameters.

Event: ESC Congress 2017

Topic: Thrombosis and platelets

Session: Drug treatment of acute coronary syndrome patients

Access
Like
Thumbnail

HDL and cardioprotection in the presence of cardiovascular risk factors. A cardiac magnetic resonance imaging-based study in a hypercholesterolemic pig model of ischemia/reperfusion.

Event: ESC Congress 2017

Topic: Ischaemia, experimental studies

Session: Coronary artery disease: from bench to bedside

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources